MR
MRN3.LSE Leverage Shares 3x Long Moderna (MRNA) ETP Securities
- USD
No recent price
- Total assets
- 770K
- Expense ratio
- 0.96%
- Dividend yield
- -
- 1-year return
- +1,021.90%
- Holdings
- 1
- Since
- 2021
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does MRN3.LSE invest in?
- Mostly US stocks (297.2%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.0%)
- Top 3 holdings: 315.2% of the fund
Asset allocation
- US stocks 297.2%
Top holdings
- Moderna Inc 315.16%
Leverage Shares 3x Long Moderna (MRNA) ETP Securities performance
Sharpe ratio 0.43- This year
- +1,021.90%
- 1 year
- +1,021.90%
- 3 years
- -93.13%
- 5 years
- 0.00%
Volatility 356.9% over 1 year and 266.3% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
MRN3.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities top holdings
315.2% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 315.16% |
MRN3.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
MRN3.LSE regional exposure
- North America100.0%
Share of the stocks in the fund.
Company size
Average market cap 90.1B- Medium cap297.2%
Leverage Shares 3x Long Moderna (MRNA) ETP Securities fund profile
- Fund name
- Leverage Shares 3x Long Moderna (MRNA) ETP Securities
- Ticker
- MRN3.LSE
- Exchange
- London Exchange
- Issuer
- Leverage Shares PLC
- Index tracked
- -
- Category
- Leveraged & Inverse Equity
- Domicile
- Ireland
- Inception date
- Dec 10, 2021
- Trading currency
- USD
- Expense ratio
- 0.96%